12-111494996-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372574.1(ATXN2):​c.1936-6216G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 151,974 control chromosomes in the GnomAD database, including 37,613 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 37613 hom., cov: 30)

Consequence

ATXN2
NM_001372574.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.02

Publications

84 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN2NM_001372574.1 linkc.1936-6216G>A intron_variant Intron 14 of 24 ENST00000673436.1 NP_001359503.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN2ENST00000673436.1 linkc.1936-6216G>A intron_variant Intron 14 of 24 NM_001372574.1 ENSP00000500925.1 A0A5F9ZI57

Frequencies

GnomAD3 genomes
AF:
0.675
AC:
102497
AN:
151856
Hom.:
37538
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.918
Gnomad AMI
AF:
0.542
Gnomad AMR
AF:
0.706
Gnomad ASJ
AF:
0.330
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.906
Gnomad FIN
AF:
0.594
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.646
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.675
AC:
102636
AN:
151974
Hom.:
37613
Cov.:
30
AF XY:
0.687
AC XY:
51027
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.918
AC:
38099
AN:
41506
American (AMR)
AF:
0.707
AC:
10778
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.330
AC:
1143
AN:
3468
East Asian (EAS)
AF:
0.998
AC:
5160
AN:
5170
South Asian (SAS)
AF:
0.906
AC:
4364
AN:
4816
European-Finnish (FIN)
AF:
0.594
AC:
6244
AN:
10504
Middle Eastern (MID)
AF:
0.626
AC:
184
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34800
AN:
67942
Other (OTH)
AF:
0.649
AC:
1370
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1394
2789
4183
5578
6972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.603
Hom.:
15530
Bravo
AF:
0.690
Asia WGS
AF:
0.943
AC:
3278
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.66
DANN
Benign
0.17
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7137828; hg19: chr12-111932800; API